| Passage of VIP/PACAP/secretin family across the blood-brain barrier: therapeutic effects D Dogrukol-Ak, F Tore, N Tuncel Current pharmaceutical design 10 (12), 1325-1340, 2004 | 119 | 2004 |
| Passage of vasoactive intestinal peptide across the blood–brain barrier D Dogrukol-Ak, WA Banks, N Tuncel, M Tuncel Peptides 24 (3), 437-444, 2003 | 65 | 2003 |
| Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock N Tunçel, F Töre, V Şahintürk, D Ak, M Tunçel Peptides 21 (1), 81-89, 2000 | 64 | 2000 |
| Influence of cigarette smoking on thyroid hormone levels A Karakaya, N Tuncel, G Alptuna, Z Kocer, G Erbay Human toxicology 6 (6), 507-509, 1987 | 61 | 1987 |
| The protective effect of vasoactive intestinal peptide (VIP) on stress‐induced gastric ulceration in rats NEŞE TUNÇEL, NI ERKASAP, V ŞAH˙ INTÜRK, DID AK, M Tuncel Annals of the New York Academy of Sciences 865 (1), 309-322, 1998 | 60 | 1998 |
| Mast cells: target and source of neuropeptides F Tore, N Tuncel Current pharmaceutical design 15 (29), 3433-3445, 2009 | 52 | 2009 |
| Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson's disease model in rats: brain microdialysis, behavior, and microscopy N Tunçel, E Şener, C Cerit, U Karasu, F Gürer, V Şahintürk, C Bayçu, D Ak, ... Peptides 26 (5), 827-836, 2005 | 50 | 2005 |
| From adipose tissue protein secretion to adipopharmacology of disease F Tore, AB Tonchev, M Fiore, N Tunçel, P Atanassova, L Aloe, ... Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly …, 2007 | 48 | 2007 |
| Triactome: neuro–immune–adipose interactions. Implication in vascular biology GN Chaldakov, M Fiore, PI Ghenev, J Beltowski, G Ranćić, N Tunçel, ... Frontiers in immunology 5, 130, 2014 | 44 | 2014 |
| Ovarian, uterine and brain mast cells in female rats: cyclic changes and contribution to tissue histamine Y Aydın, N Tunçel, F Gürer, M Tunçel, M Koşar, G Oflaz Comparative Biochemistry and Physiology Part A: Molecular & Integrative …, 1998 | 43 | 1998 |
| Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF … OT Korkmaz, N Tunçel, M Tunçel, EM Öncü, V Şahintürk, M Çelik Journal of molecular neuroscience 41 (2), 278-287, 2010 | 42 | 2010 |
| Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum N Tunçel, OT Korkmaz, N Tekin, E Şener, F Akyüz, M Inal Journal of Molecular Neuroscience 46 (1), 51-57, 2012 | 38 | 2012 |
| A simple and sensitive LC–ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates D Yeniceli, E Şener, OT Korkmaz, D Doğrukol-Ak, N Tuncel Talanta 84 (1), 19-26, 2011 | 37 | 2011 |
| Protective effect of vasoactive intestinal peptide on testicular torsion-detorsion injury: association with heparin-containing mast cells C Can, F Töre, N Tunçel, O Uysal, F Gürer, D Ak, M Tunçel Urology 63 (1), 195-200, 2004 | 37 | 2004 |
| Protection of rat retina from ischemia-reperfusion injury by vasoactive intestinal peptide (VIP): the effect of VIP on lipid peroxidation and antioxidant enzyme activity of … N Tuncel, H Basmak, K Uzuner, M Tuncel, G Altiokka, V Zaimoglu, A Ozer, ... ANNALS-NEW YORK ACADEMY OF SCIENCES 805, 489-498, 1996 | 31 | 1996 |
| Mast cell degranulation in hemorrhagic shock in rats and the effects of vasoactive intestinal peptide, aprotinin and H1 and H2-receptor blockers on degranulation H Tıkız, N Tunçel, F Gürer, C Baycu Pharmacology 43 (1), 47-52, 1991 | 27 | 1991 |
| Adipose tissue and mast cells GN Chaldakov, AB Tonchev, N Tuncel, P Atanassova, L Aloe Adipose Tissue and Adipokines in Health and Disease, 151-158, 2007 | 26 | 2007 |
| The effect of vasoactive intestinal peptide (VIP) on mast cell invasion/degranulation in testicular interstitium of immobilized+ cold stressed and β-endorphin-treated rats N Tunçel, F Gürer, E Aral, K Uzuner, Y Aydin, C Bayçu Peptides 17 (5), 817-824, 1996 | 26 | 1996 |
| Ischemic-reperfused rat skeletal muscle: The effect of vasoactive intestinal peptide (VIP) on contractile force, oxygenation and antioxidant enzyme systems N Tunçel, S Erden, K Uzuner, G Altiokka, M Tunçel Peptides 18 (2), 269-275, 1997 | 23 | 1997 |
| Effects of sepsis on mast cells in rat dura mater: influence of L-NAME and VIP F Tore, AM Reynier-Rebuffel, N Tuncel, J Callebert, P Aubineau British journal of pharmacology 134 (7), 1367, 2001 | 22 | 2001 |
orhan tansel korkmazEskisehir Osmangazi University , School of Medicine, Department of Physiologybu.edu üzerinde doğrulanmış e-posta adresine sahip
